Keybank National Association Chemo Centryx, Inc. Transaction History

Keybank National Association

$25.6 Billion
Q4 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Jan 30, 2019	SELL	$9.15 - $12.26 $207,293 - $277,750	-22,655 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$10.49 - $13.72 $69,076 - $90,346	-6,585 Reduced 22.52%	22,655 $286,000
Q2 2018 Aug 08, 2018	SELL	$10.62 - $13.98 $175,230 - $230,670	-16,500 Reduced 36.07%	29,240 $385,000
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $31,281 - $79,476	5,302 Added 13.11%	45,740 $622,000
Q3 2017 Nov 02, 2017	SELL	$6.5 - $10.69 $94,536 - $155,475	-14,544 Reduced 26.45%	40,438 $300,000
Q4 2016 May 14, 2018	BUY	N/A	54,982	54,982 $407,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.